Guided Therapeutics (OTCMKTS:GTHP) Issues Quarterly Earnings Results

Guided Therapeutics (OTCMKTS:GTHP) posted its quarterly earnings results on Monday. The company reported ($0.02) earnings per share for the quarter, Zacks reports.

Guided Therapeutics Stock Down 16.0 %

Shares of OTCMKTS:GTHP opened at $0.08 on Wednesday. The firm has a fifty day simple moving average of $0.11 and a two-hundred day simple moving average of $0.15. The stock has a market capitalization of $6.52 million, a P/E ratio of -2.79 and a beta of 0.50. Guided Therapeutics has a 52 week low of $0.06 and a 52 week high of $0.23.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.